Belluscura Plc (BELL) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Belluscura US subsidiary secures $4m credit facility
22 November 2024 12:36
(Sharecast News) - Belluscura, a developer of lightweight, portable oxygen enrichment devices, announced on Friday that its subsidiary Belluscura LLC has secured a $4m credit facility from Sallyport...
-
Belluscura group revenues continue to grow YTD
28 October 2024 10:42
(Sharecast News) - Medical device developer Belluscura said on Monday that group revenue had continued to in the nine months ended 26 September.
-
Belluscura shares surge on strong sales momentum, improved outlook
27 August 2024 12:03
(Sharecast News) - Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full...
-
Belluscura makes 'significant progress', proposes placing
12 June 2024 08:42
(Sharecast News) - Medical device developer Belluscura said on Wednesday that it had made "significant progress" in recent months and proposed a fundraising of up to £2.4m.
-
Belluscura enters partnership with Sunset HealthCare
13 February 2024 15:16
(Sharecast News) - Belluscura announced a partnership with Sunset HealthCare Solutions, a Chicago-based manufacturer and distributor of home medical equipment, on Tuesday.
-
Belluscura bid for TMT Acquisition goes unconditional
9 February 2024 11:52
(Sharecast News) - Belluscura announced on Friday that the all-share offer for the acquisition of TMT Acquisition had gone unconditional.
-
Belluscura confident in outlook after getting China approval
20 December 2023 14:07
(Sharecast News) - Belluscura has gained approval to distribute its X-PLOR portable oxygen concentrator (POC) in China, it announced on Wednesday, under a licensing agreement with InnoMax Medical Device...
-
Belluscura oxygen concentrator approved in Singapore
12 December 2023 12:10
(Sharecast News) - Belluscura, a medical device developer specialising in portable oxygen enrichment technology, announced approval from the Singapore Health Sciences Authority to distribute its...
-
Belluscura signs 10-year licensing deal in China, Asian markets
30 August 2023 14:16
(Sharecast News) - Medical device developer Belluscura announced a 10-year exclusive licence, marketing and distribution agreement with InnoMax Medical Technology on Wednesday.
-
Belluscura receives 6,500 orders for new oxygen concentrator
16 August 2023 09:50
(Sharecast News) - Medical device developer Belluscura announced on Wednesday that it had received purchase orders for more than 6,500 units of its next-generation 'DISCOV-R' portable oxygen...
-
Belluscura oxygen concentrator launched on GoodRx platform
24 February 2023 14:59
(Sharecast News) - Belluscura announced on Friday that its 'X-PLOR' portable oxygen concentrator (POC) was now available in the US through GoodRx, making it the first medical device in its field...
-
Belluscura makes 'considerable progress' in 2022
13 January 2023 17:12
(Sharecast News) - Portable oxygen concentrator developer Belluscura described "considerable progress" in a trading update on Friday, reporting that since the launch of its first-generation...
Company announcements Announcements
-
Appointment of Allenby Capital as Joint Broker
20 December 2024 15:20
Belluscura
-
Holding(s) in Company
11 December 2024 15:21
Belluscura
-
New Wound Care Joint Venture
3 December 2024 07:00
Belluscura
-
New $4million Credit Facility
22 November 2024 07:00
Belluscura
-
Holding(s) in Company
12 November 2024 16:34
Belluscura
-
Trading Update
28 October 2024 07:00
Belluscura
-
Half-year Report
26 September 2024 07:00
Belluscura
-
Holding(s) in Company
13 September 2024 13:37
Tekcapital
-
Holding(s) in Company
12 September 2024 15:05
Belluscura
-
Result of General Meeting
27 August 2024 14:17
Belluscura
-
AGM Trading Statement
27 August 2024 07:00
Belluscura
-
Notice of AGM
2 August 2024 07:00
Belluscura
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.